| Literature DB >> 32095810 |
Frank Sandmann1,2, Mark Jit1,2, Nick Andrews1, Hannah L Buckley3, Helen Campbell4, Sonia Ribeiro4, Bersabeh Sile4, Julia Stowe4, Elise Tessier4, Mary Ramsay4, Yoon H Choi1, Gayatri Amirthalingam4.
Abstract
In October 2012, a maternal pertussis vaccination program was implemented in England following an increased incidence and mortality in infants. We evaluated the cost-effectiveness of the program by comparing pertussis-related infant hospitalizations and deaths in 2012-2017 with nonvaccination scenarios. Despite considerable uncertainties, findings support the cost-effectiveness of the program. © Crown copyright 2020.Entities:
Keywords: economic evaluation; maternal pertussis vaccination; pertussis vaccine; postimplementation; whooping cough
Year: 2020 PMID: 32095810 DOI: 10.1093/cid/ciaa165
Source DB: PubMed Journal: Clin Infect Dis ISSN: 1058-4838 Impact factor: 9.079